JP2005501855A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501855A5
JP2005501855A5 JP2003521215A JP2003521215A JP2005501855A5 JP 2005501855 A5 JP2005501855 A5 JP 2005501855A5 JP 2003521215 A JP2003521215 A JP 2003521215A JP 2003521215 A JP2003521215 A JP 2003521215A JP 2005501855 A5 JP2005501855 A5 JP 2005501855A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
unsubstituted
compound represented
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003521215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501855A (ja
JP4344241B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/008888 external-priority patent/WO2003016289A1/en
Publication of JP2005501855A publication Critical patent/JP2005501855A/ja
Publication of JP2005501855A5 publication Critical patent/JP2005501855A5/ja
Application granted granted Critical
Publication of JP4344241B2 publication Critical patent/JP4344241B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003521215A 2001-08-17 2002-08-08 トリアジン誘導体、およびサンスクリーンとしてのその使用 Expired - Fee Related JP4344241B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01810796 2001-08-17
CH16992001 2001-09-14
PCT/EP2002/008888 WO2003016289A1 (en) 2001-08-17 2002-08-08 Triazine derivatives and their use as sunscreens

Publications (3)

Publication Number Publication Date
JP2005501855A JP2005501855A (ja) 2005-01-20
JP2005501855A5 true JP2005501855A5 (enExample) 2006-01-05
JP4344241B2 JP4344241B2 (ja) 2009-10-14

Family

ID=25739004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521215A Expired - Fee Related JP4344241B2 (ja) 2001-08-17 2002-08-08 トリアジン誘導体、およびサンスクリーンとしてのその使用

Country Status (7)

Country Link
US (1) US7038046B2 (enExample)
EP (1) EP1423371B1 (enExample)
JP (1) JP4344241B2 (enExample)
AT (1) ATE485281T1 (enExample)
DE (1) DE60238066D1 (enExample)
DK (1) DK1423371T3 (enExample)
WO (1) WO2003016289A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6748471B1 (en) * 2000-10-16 2004-06-08 Electronics For Imaging, Inc. Methods and apparatus for requesting and receiving a print job via a printer polling device associated with a printer
US7574545B2 (en) * 2000-10-16 2009-08-11 Electronics For Imaging, Inc. Method and apparatus for controlling a document output device with a control request stored at a server
FR2867188A1 (fr) * 2004-03-03 2005-09-09 Oreal Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri
US20070286827A1 (en) * 2006-06-12 2007-12-13 Esschem, Inc. Optical brighter and uv stabilizer for acrylic enhancements
EP2037746A4 (en) * 2006-06-29 2010-09-22 Martek Biosciences Corp GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR
BRPI0714634B8 (pt) * 2006-08-24 2016-03-29 Unilever Nv composição cosmética fotoestável.
US20080096782A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous systems containing phospholipid, surfactant and phosphate ester for water-insoluble materials
US20080097070A1 (en) * 2006-10-19 2008-04-24 L'oreal Aqueous polyamine-containing systems for water-insoluble materials
CN102985557B (zh) 2009-03-13 2018-06-15 安吉奥斯医药品有限公司 用于细胞增殖相关病症的方法和组合物
PE20120693A1 (es) 2009-06-29 2012-07-04 Agios Pharmaceuticals Inc Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
WO2011050210A1 (en) 2009-10-21 2011-04-28 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
KR20130070608A (ko) 2010-05-10 2013-06-27 세게티스, 인코포레이티드. 미립자 고체에 대한 분산제 및 슬립제로서의 알킬 케탈 에스터 및 그의 제조방법, 및 용도
KR101856808B1 (ko) 2010-12-28 2018-05-10 닛산 가가쿠 고교 가부시키 가이샤 폴리이미드막 형성용 도포액, 액정 배향제, 폴리이미드막, 액정 배향막 및 액정 표시 소자
WO2012092546A2 (en) * 2010-12-30 2012-07-05 L'oreal S.A. Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax
PT3406251T (pt) 2011-05-03 2024-01-24 Agios Pharmaceuticals Inc Ativadores da piruvato-cinase para utilização em terapia
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
SMT201800334T1 (it) 2012-01-06 2018-09-13 Agios Pharmaceuticals Inc Composti terapeuticamente attivi e loro metodi di utilizzo
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
WO2014062511A1 (en) 2012-10-15 2014-04-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
MX375030B (es) 2013-07-11 2025-03-06 Agios Pharmaceuticals Inc Compuestos de n,6-bis(aril o heteroaril)-1,3,5-triazin-2,4-diamina como inhibidores de idh2 mutantes para el tratamiento de cancer.
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
CN105593215B (zh) 2013-07-11 2019-01-15 安吉奥斯医药品有限公司 用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
WO2015010297A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
PH12021551647A1 (en) 2014-03-14 2022-06-06 Agios Pharmaceuticals Inc Pharmaceutical compositions of therapeutically active compounds
MX384883B (es) 2015-06-11 2025-03-14 Agios Pharmaceuticals Inc Métodos para usar activadores de piruvato cinasa.
HUE067449T2 (hu) 2015-10-15 2024-10-28 Servier Lab Ivozidenib, citarabin és daunorubicin vagy idarubicin kombinációs terápa akut mielogén leukémia kezelésére
MD3362066T2 (ro) 2015-10-15 2022-08-31 Les Laboratoires Servier Sas Terapie combinată pentru tratamentul tumorilor maligne
CN107827764A (zh) * 2017-11-27 2018-03-23 上海应用技术大学 一种双β‑氨基酮或双β‑氨基酯类的制备方法
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4105923A1 (de) 1991-02-26 1992-08-27 Basf Ag P-aminozimtsaeure-substituierte triazine
DE4223890A1 (de) * 1992-02-19 1993-08-26 Merck Patent Gmbh Triazin-derivate
FR2744721B1 (fr) * 1996-02-12 1999-06-18 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations

Similar Documents

Publication Publication Date Title
JP2005538072A5 (enExample)
JP2006515613A5 (enExample)
RU2203894C2 (ru) Новые производные пиримидина (варианты)
JP2009519993A5 (enExample)
PE20130385A1 (es) Derivados del acido naft-2-ilacetico para tratar el sida
RU2007139453A (ru) Гетеробициклические ингибиторы вируса гепатита с (hcv)
JP2005535586A5 (enExample)
AR037485A1 (es) Uso de un compuesto derivado de pirazol-triazina en la fabricacion de un medicamento, medicamento que comprende un compuesto derivado de pirazol-triazina, producto industrial y composicion farmaceutica
JP2005523922A5 (enExample)
JP2012508252A5 (enExample)
RU2004130488A (ru) Пиримидиновые производные
RU2009133470A (ru) Макроциклические фенилкарбаматы, ингибирующие hcv
JP2007501831A5 (enExample)
DK1423371T3 (da) Triazinderivater og anvendelse deraf som solbeskyttelse
JP2012512863A5 (enExample)
JP2005529869A5 (enExample)
JP2007530637A5 (enExample)
JP2019535694A5 (enExample)
PE20030455A1 (es) Ciclohexilsulfonas como moduladores del procesamiento de proteina precursora amiloide por gamma secretasa
RU2006138663A (ru) Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
RU2010147826A (ru) Ацилоксиалкилкарбаматные пролекарства, способы синтеза и применение
RU2004126637A (ru) Производные порфиринплатины, терапевтические активное соединение для получения средства для лечения опухолей, лекарственное средство и способ получения указанного средства
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
JP2006517932A5 (enExample)
JP2003026675A5 (enExample)